Iberogast celebrates its 50th Birthday |
| Apr 05 2010 |
Iberogast (STW 5) has celebrated its golden anniversary with a conference in Germany entitled, “50 Years of Iberogast”.
During its 50 years of development and use, Iberogast has become one of the most extensively investigated herbal medicinal products and is verified by the highest levels of scientific evidence for the treatment of functional gastrointestinal disease e.g. IBS and dyspepsia.
The key to Iberogast’s golden success is it follows “Seed to Patient” principles. This means a fully controlled process is followed from the growing of the seeds all the way through to the finishing of the product. The result is a genuinely standardised product, which can be used in clinical trials. Clinical studies include 5 randomised, double-blind clinical trials, 12 open trials, 2 post marketing surveillances, 2 experience reports, and a cohort study, as well as 2 metaanalyses. In total, the research on Iberogast has incorporated 45,000 patients.
Iberogast is a truly golden herbal icon, which has been used by 25 million patients worldwide in 17 countries.